1Polizzi D, Pratesi G, Tortoreto M et al . Of human tumor xenografts. Cancer Res, 1999,59(5) : 1 036
2Edward, DR, Berg, WB, Spriggs, DR et al . MDL - 27048, anovel synthetic microtubule inhibitor, exerts curative antitumoral activity in vitro, show efficacy toward multidrug- resistant tufter cells, and lacks neurotoxicity. Clin Cancer Res,2004, S6,563
3Donehower, RC, Schwartz, G, Wolf AC et al . MDL - 27048, anovel synthetic microtubule inhibitor, exerts curative antitumoral activity in vitro, show efficacy toward muhidrug - resistant tumor cells, and lacks neurotoxicity. Clin Cancer Res,2004,S6,564
4Wheeler GP, Bowdon BJ, Temple CJ et al . Biological effects and structure2activity relationships of 1 , 22dihydropy2 rido [3 , 42b] pyrazines. Cancer Res, 1983,43(8) :3 567
5Yamamoto K, Noda K, Yoshimura A et al . Inhibition of microtubules and cell cycle arrest by a new 12deaza27 ,82di2 hydropteridine antitumour drug, C12980, and by its chiral isomer, NSC 613863. Cancer Chem Pharmacol 2003,42,127
6Raynaud FI, Kelland LR, Walton MI et al. Preclinical pharmacology of 1069C85, a novel tubulin binder. Curr Opin Pharmacol,2004,1,370
7Jiang JD, Roboz J, Weisz I et al . Synthesis, cancericidal and antimicrotubule activities of 32(haloacetamido) 2benzoy2 lureas. Anticancer Drug Des, 1998,13(7) :735
8Li JN, Song DQ, Lin YH et al . Inhibition of microtu2 bule polymerization by 32bromopropionylamino benzoylurea (J IMBO1 ) ,a new cancericidal tubulin ligand. Biochem Pharmacol,2003,65(10): 1 691
9Okada H, Koyanagi T, Yamada N et al . Synthesis and antitumor activities of novel benzoylphenylurea derivatives. Chem Pharm Bull (Tokyo), 1991,39(9):2 308
10Santha E, Medina JC, Shah B et al . Antimicrotubule effects of the novel antitumor benzoylphenylurea derivative HO 2221. Cancer Chemother Pharmacol, 2005,3,37
